Australian biotech market today 22.05.09
Friday, 22 May, 2009
As of 3.30pm, Healthcare index is down 1% on the back of a general 1.3% drop experienced by the All Ordinaries sparked by global economic concerns.
CSL dropped 50c to $30.90 and ResMed (ASX:RMD) is also down fractionally, along with the rest of the market.
Cochlear (ASX:COH) bucked the trend by rising $1.01 to $53.01, as did Ramsay Health Care (ASX:RHC), which gained 1.1%.
Ansell (ASX:ANN) shed 39 cents to $8.21 after Barclays Group issued a notice of ceasing to be a substantial holder from 18 May.
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
